Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Potent Tau Aggregation Inhibitor D-Peptides Selected against Tau-Repeat 2 Using Mirror Image Phage Display 2021-09-12
  2. Early detection of Alzheimer's disease by peptides from phage display screening 2019-06-24

Studies

2 studies carry this tag.

Date range

2019 to 2021

Top journals

  • Brain research 1
  • Chembiochem : a European journal of chemical biology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Potent Tau Aggregation Inhibitor D-Peptides Selected against Tau-Repeat 2 Using Mirror Image Phage Display

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Chembiochem : a European journal of chemical biology 2021-09-12 Drug development

    Alzheimer's disease and other Tauopathies are associated with neurofibrillary tangles composed of Tau protein, as well as toxic Tau oligomers.

  2. Early detection of Alzheimer's disease by peptides from phage display screening

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Brain research 2019-06-24 Biomarkers

    Alzheimer's disease (AD) is the most common neurodegenerative disorder without effective treatment so far.

All topic tags with their study counts